Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Rheumatic diseases such as SLE, SS, SSc, vasculitis syndrome
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Optimal treatment and management of Rheumatoid Arthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Education relating to Etiology, diagnosis, treatment and, management of Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Hemophilia: Improve general knowledge level of gene therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Serotyping of Streptococcus pneumoniae
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Artificial Intelligence/Machine Learning Research in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan